A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

NCT02590965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Fruquintinib
DRUG: Placebo

Sponsor

Hutchison Medipharma Limited

Collaborators

[object Object]